Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Ischemia
Clinical trial NCT02369809 · COMPLETED
Trial details
- NCT number
- NCT02369809
- Sponsor
- Artgen Biotech
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2017-01-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.